AMERICAN VANGUARD CORPORATION (NYSE:AVD) Files An 8-K Results of Operations and Financial Condition

Item2.02 Results of Operations and Financial Condition

On March6, 2017, American Vanguard Corporation (Registrant)
issued a press release announcing its financial results for the
fourth quarter and fiscal year ended December31, 2016. In the
body of that press release, specifically in the table entitled
ANALYSIS OF SALES, Years ended December31, 2016, 2015, and 2014
the figure for Net sales in 2014 was mistakenly reported as
$2,634, when it should have been reported as $2,634. The
full text of the press release, including the correction
indicated in the immediately preceding sentence, is attached
hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K,
including the Exhibits attached hereto, is being furnished under
Items 2.02, 8.01 and 9.01 and shall not be deemed filed for
purposes of Section18 of the Securities Exchange Act of 1934, as
amended (the Exchange Act), or incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.

Item8.01 Other Items

On March7, 2017, the Board of Directors of Registrant declared a
cash dividend of one and one-half cents ($0.015) per share of
common stock of Registrant to shareholders of record as of
March31, 2017 to be distributed on April14, 2017. On March10,
2017, Registrant issued a press release announcing this dividend
declaration. The full text of that press release is attached
hereto as Exhibit 99.2 and is incorporated herein by reference.

Also on March7, 2017, the Board of Directors of Registrant set
the date of its 2017 Annual Stockholders Meeting (the Annual
Meeting) to take place on June6, 2017 with a record date of
April11, 2017. The Annual Meeting will be a web-hosted, virtual
meeting (as was the case in 2016). Further details will appear in
the Registrants 2017 proxy statement to be filed and made
available in April 2017.

Item9.01 Financial Statements and Exhibits.

About AMERICAN VANGUARD CORPORATION (NYSE:AVD)

American Vanguard Corporation (AVD) operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV) and Envance Technologies, LLC (Envance). The Company, through AMVAC, develops and markets products for agricultural, commercial and consumer uses. The Company manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals, which include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, are marketed in liquid, powder, and granular forms.

AMERICAN VANGUARD CORPORATION (NYSE:AVD) Recent Trading Information

AMERICAN VANGUARD CORPORATION (NYSE:AVD) closed its last trading session down -0.15 at 15.05 with 132,318 shares trading hands.